A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)

Kurzanzeige
dc.contributor.authorRummel, Mathias J.
dc.contributor.authorJanssens, Ann
dc.contributor.authorMacDonald, David
dc.contributor.authorKeating, Mary-Margaret
dc.contributor.authorZaucha, Jan M.
dc.contributor.authorDavis, Jaclyn
dc.contributor.authorLasher, Janet
dc.contributor.authorBabanrao Pisal, Chaitali
dc.contributor.authorIzquierdo, Miguel
dc.contributor.authorFriedberg, Jonathan W.
dc.date.accessioned2022-11-24T08:07:07Z
dc.date.available2022-11-24T08:07:07Z
dc.date.issued2021
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/9724
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-9112
dc.language.isoen
dc.rightsNamensnennung - Nicht kommerziell 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddcddc:610
dc.titleA phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.epage1133
local.source.journaltitleBritish journal of haematology
local.source.spage1123
local.source.urihttps://doi.org/10.1111/bjh.17420
local.source.volume193

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
10.1111_bjh.17420.pdf
Größe:
446.77 KB
Format:
Adobe Portable Document Format
Beschreibung:
Herunterladen

Sammlungen

Publikationen im Open Access gefördert durch die UB